Novel Once-Weekly Insulin Shines for Type 2 Diabetes

(MedPage Today) -- A novel insulin formulation given once weekly was as safe and effective as a conventional daily insulin product for type 2 diabetes, a randomized, placebo-controlled phase II trial showed.
Compared with once-daily insulin glargine...